FAQ

4-dedimethylamino sancycline

Known as: 4-Dimethlyamino Sancycline, 4-Dimethlyaminosancycline, 4-dedimethylaminosancycline 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2013
01219992013

Related topics

Related topics

2 relations
CMT-3Incyclinide

Related mentions per year

Related mentions per year

1997-2017
1990200020102020
4-dedimethylamino sancycline
CMT-3
Incyclinide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Mixture of nonionic/ionic surfactants for the formulation of nanostructured lipid carriers: effects on physical properties.
The objective of the present work was to investigate the effects of the mixture of nonionic/ionic surfactants on nanostructured… (More)
Is this relevant?
2013
2013
Preparation and characterization of 4-dedimethylamino sancycline (CMT-3) loaded nanostructured lipid carrier (CMT-3/NLC) formulations.
Chemically modified tetracyclines (CMTs) have been reported to strongly inhibit proliferation and metastasis of various cancers… (More)
Is this relevant?
1999
1999
Spectrophotometric determination of acidity constants of 4-dedimethylamino sancycline (Col-3), a new antitumor drug.
A spectrophotometric technique was used to determine the acidity constants of 4-dedimethylamino sancycline (Col-3), a new… (More)
Is this relevant?
1999
1999
Degradation kinetics of 4-dedimethylamino sancycline, a new anti-tumor agent, in aqueous solutions.
The kinetics of degradation of the new anti-tumor drug, 4-dedimethylamino sancycline (col-3) in aqueous solution at 25oC were… (More)
Is this relevant?